KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCapital LeasesCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesFinished GoodsGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsNon-Current Deffered RevenueNotes PayablesOperating LeasesOther Non-Current AssetsPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesReceivables - NetRetained EarningsShareholder's EquityShort-term InvestmentsTotal Current LiabilitiesTotal LiabilitiesTreasury SharesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Bionano Genomics (BNGO) Total Non-Current Liabilities (2017 - 2024)

Historic Total Non-Current Liabilities for Bionano Genomics (BNGO) over the last 8 years, with Q4 2024 value amounting to $41.3 million.

  • Bionano Genomics' Total Non-Current Liabilities fell 6153.49% to $41.3 million in Q4 2024 from the same period last year, while for Dec 2024 it was $41.3 million, marking a year-over-year decrease of 6153.49%. This contributed to the annual value of $41.3 million for FY2024, which is 6153.49% down from last year.
  • Latest data reveals that Bionano Genomics reported Total Non-Current Liabilities of $41.3 million as of Q4 2024, which was down 6153.49% from $38.5 million recorded in Q3 2024.
  • In the past 5 years, Bionano Genomics' Total Non-Current Liabilities registered a high of $107.4 million during Q4 2023, and its lowest value of $17.9 million during Q3 2021.
  • In the last 5 years, Bionano Genomics' Total Non-Current Liabilities had a median value of $41.3 million in 2024 and averaged $41.3 million.
  • Its Total Non-Current Liabilities has fluctuated over the past 5 years, first surged by 13786.28% in 2023, then crashed by 6153.49% in 2024.
  • Quarter analysis of 5 years shows Bionano Genomics' Total Non-Current Liabilities stood at $25.4 million in 2020, then rose by 21.87% to $30.9 million in 2021, then skyrocketed by 45.99% to $45.1 million in 2022, then skyrocketed by 137.86% to $107.4 million in 2023, then tumbled by 61.53% to $41.3 million in 2024.
  • Its Total Non-Current Liabilities stands at $41.3 million for Q4 2024, versus $38.5 million for Q3 2024 and $43.3 million for Q2 2024.